Point-of-care testing: One solution to global healthcare

Point-of-care diagnostic testing provides immediate, actionable results, right where you need them. The time has come to bring the healthcare to the people.

point-of-care
point-of-care
point-of-care

Point-of-care diagnostic testing transforms healthcare

Expanding Global Access Expanding Global Access Expanding Global Access
Expanding Global Access

In fact, each year, Abbott alone delivers over one billion tests worldwide.

Shortening Treatment Time Shortening Treatment Time Shortening Treatment Time
Shortening Treatment Time

For example: HIV patients who were tested with a POC device received antiretroviral therapy (ART) treatment 130 days faster than those diagnosed with the help of a traditional lab.1

Improving Outcomes Improving Outcomes Improving Outcomes
Improving Outcomes

Case in point: heart failure patients who received a POC test were discharged from the hospital 3 days sooner than those who didn’t have the advantage of POC testing, improving both economic and healthcare outcomes.2

Point-of-care diagnostic testing transforms healthcare

Expanding Global Access Expanding Global Access Expanding Global Access

 

Expanding Global Access

 

In fact, each year, Abbott alone delivers over one billion tests worldwide.

Shortening Treatment Time Shortening Treatment Time Shortening Treatment Time

 

Shortening Treatment Time

 

For example: HIV patients who were tested with a POC device received antiretroviral therapy (ART) treatment 130 days faster than those diagnosed with the help of a traditional lab.

Improving Outcomes Improving Outcomes Improving Outcomes

 

Improving Outcomes

 

Case in point: heart failure patients who received a POC test were discharged from the hospital 3 days sooner than those who didn’t have the advantage of POC testing, improving both economic and healthcare outcomes.

Find your point-of-care solution

Discover how Abbott diagnostic testing solutions can help solve some of the world’s great healthcare challenges – including yours.

References

  1. Wynberg E et al. Impact of point-of-care CD4 testing on linkage to HIV care: a systematic review. Journal of the International AIDS Society (2014)17:18809-18815.
  2. Mueller C, Scholer A, Laule-Lilian K, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med. 2004

©2024 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.

Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. GDPR Statement.

Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.

Abbott - A Leader in Rapid Point-of-Care Diagnostics.